Kelly PM - Search Results

1

Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles.

Kelly PM, Bright SA, Fayne D, Pollock JK, Zisterer DM, Williams DC, Meegan MJ. Kelly PM, et al. Bioorg Med Chem. 2016 Sep 15;24(18):4075-4099. doi: 10.1016/j.bmc.2016.06.050. Epub 2016 Jun 29. Bioorg Med Chem. 2016. PMID: 27407030

2

Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer.

Greene LM, Wang S, O'Boyle NM, Bright SA, Reid JE, Kelly P, Meegan MJ, Zisterer DM. Greene LM, et al. Oncol Rep. 2013 Jun;29(6):2451-8. doi: 10.3892/or.2013.2379. Epub 2013 Apr 3. Oncol Rep. 2013. PMID: 23564200

3

Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.

Kelly PM, Keely NO, Bright SA, Yassin B, Ana G, Fayne D, Zisterer DM, Meegan MJ. Kelly PM, et al. Molecules. 2017 Aug 31;22(9):1440. doi: 10.3390/molecules22091440. Molecules. 2017. PMID: 28858267 Free PMC article.

4

Synthesis and evaluation of antiproliferative microtubule-destabilising combretastatin A-4 piperazine conjugates.

O'Boyle NM, Ana G, Kelly PM, Nathwani SM, Noorani S, Fayne D, Bright SA, Twamley B, Zisterer DM, Meegan MJ. O'Boyle NM, et al. Among authors: kelly pm. Org Biomol Chem. 2019 Jun 26;17(25):6184-6200. doi: 10.1039/c9ob00558g. Org Biomol Chem. 2019. PMID: 31173031

5

Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer.

Ana G, Kelly PM, Malebari AM, Noorani S, Nathwani SM, Twamley B, Fayne D, O'Boyle NM, Zisterer DM, Pimentel EF, Endringer DC, Meegan MJ. Ana G, et al. Among authors: kelly pm. Pharmaceuticals (Basel). 2021 Feb 22;14(2):169. doi: 10.3390/ph14020169. Pharmaceuticals (Basel). 2021. PMID: 33671674 Free PMC article.

6

Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review.

Banka-Cullen SP, Comiskey C, Kelly P, Zeni MB, Gutierrez A, Menon U. Banka-Cullen SP, et al. Harm Reduct J. 2023 Jun 23;20(1):78. doi: 10.1186/s12954-023-00812-y. Harm Reduct J. 2023. PMID: 37353762 Free PMC article. Review.

7

'Selling their souls?' Nurses' understanding of addiction and recovery in acute hospital settings.

Cafferkey SL, Kelly P, Comiskey C. Cafferkey SL, et al. Br J Nurs. 2024 Feb 22;33(4):188-192. doi: 10.12968/bjon.2024.33.4.188. Br J Nurs. 2024. PMID: 38386531

8

PANORAMIC: important insights into molnupiravir use in COVID-19.

Kidd MR, Kelly PM. Kidd MR, et al. Among authors: kelly pm. Lancet. 2023 Jan 28;401(10373):250-251. doi: 10.1016/S0140-6736(22)02593-4. Epub 2022 Dec 22. Lancet. 2023. PMID: 36566762 Free PMC article. No abstract available.

9

Children's Hip Predictive (CHiP) Score: A Triage Tool for Hip Dislocation in Children Referred With Suspected Hip Dysplasia.

Murphy EP, Howells C, Gallagher O, Kelly PM, O'Kelly P, Noel J, Moore D, O'Toole PJ, Kennedy J. Murphy EP, et al. Among authors: kelly pm. J Pediatr Orthop. 2022 Nov-Dec 01;42(10):552-557. doi: 10.1097/BPO.0000000000002239. Epub 2022 Aug 22. J Pediatr Orthop. 2022. PMID: 35993600

10

Commentary: Mechanisms of kwashiorkor-associated immune suppression: Insights from human, mouse, and pig studies.

Gonzales GB, Bourke CD, Sturgeon JP, Njunge JM, Robertson RC, Kelly PM, Berkley JA. Gonzales GB, et al. Among authors: kelly pm. Front Immunol. 2022 Jul 25;13:959465. doi: 10.3389/fimmu.2022.959465. eCollection 2022. Front Immunol. 2022. PMID: 35958616 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page